Health Authority seeks simplification of procedures
The Argentine Health Authority (ANMAT) has launched a public consultation aimed at simplifying the registration of almost 30 pharmaceutical active ingredients. The list includes both nonprescription, referred to as “over-the-counter” (OTC), and prescription medicines.
The goal of the project is the unification of the technical assessment and the first batch authorization, so both requirements are performed in only one procedure. Please click here to see the project (only Spanish version available).
ANMAT estimates that, if the project is approved, the assessment time for some procedures would be reduced by 85 percent.
The rules proposed in the project would affect products containing the following active ingredients: amoxicillin, atenolol, cephalexin, ciprofloxacin, dexamethasone, enalapril, ibuprofen, metformin, paracetamol, salbutamol, acyclovir and ranitidine, among others.
The consultation is open to everyone. Should you require any further information, please contact us.
The materials available at this blog are for informational purposes only and not for the purpose of providing legal advice. You should contact your attorney or Moeller IP directly to obtain advice with respect to any particular issue or problem. Use of and access to this blog or any of the links contained within the blog do not create an attorney-client relationship between Moeller IP and the user or browser. The opinions expressed at or through this site are the opinions of the individual author and may not reflect the opinions of the firm or any individual attorney.